Top News

ADVENTRX Becomes Mast Therapeutics

San Diego-based ADVENTRX Pharmaceuticals announced this morning that it has renamed itself Mast Therapeutics. The firm also said it has swapped its ticker symbol to MSTX on the NYSE market. The firm, which is developing treatments for sickle cell disease and acute limb ischemia, did not give a reason for the name change.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel